BNP in septic patients without systolic myocardial dysfunction

European Journal of Internal Medicine

Volumn 17, Issue 8, 2006, Pages 536-540

  Shor, Renana ^a   Rozenman, Yoseph ^a   Bolshinsky, Aharon ^a   Harpaz, David ^a   Tilis, Yulian ^a   Matas, Zipora ^a   Fux, Asora ^a   Boaz, Mona ^a   Halabe, Aaron ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

BNP; Diastolic; Myocardial dysfunction; Sepsis; Septic shock; Systolic

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; INTERLEUKIN 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DEATH; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE FAILURE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; LABORATORY TEST; MALE; MYOCARDIAL DISEASE; PROTEIN BLOOD LEVEL; SCORING SYSTEM; SEPSIS; SEPTIC SHOCK;

EID: 36248955216     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejim.2006.07.013     Document Type: Article

References (21)

1. Costello L.C., Boerrigter G., and Burnett Jr. J.C. Revisiting salt and water retention: new diuretics, aquaretics, and natriuretics. Med Clin North Am 87 (2003) 475-491
2. Muskoyama M., Nakao K., Hosada K., Suga S., Saito Y., Ogawa Y., et al. Brain natriuretic peptide as novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. J Clin Invest 88 (1991) 1402
3. Ndrepepa G., Braun S., Mehilli J., von Beckerath N., Ving W., Schomig A., et al. Plasma levels of N-terminal pro-brain natriuretic peptide in patients with coronary artery disease and relation to clinical presentation, angiographic severity, and left ventricular ejection fraction. Am J Cardiol 95 5 (Mar 1 2005) 553-557
4. Bassan R., Potsch A., Maisel A., Tura B., Villacorta H., Nogueira M.V., et al. B-type natriuretic peptide: a novel early blood marker of acute myocardial infraction in patients with chest pain and no ST-segment elevation. Eur Heart J 26 3 (Feb 2005) 234-240
5. Doust J.A., Pietrzak E., Dobson A., and Glasziou P. How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review. BMJ 330 7492 (Mar 19 2005) 625
6. Bone R.C., Black R.A., Cerra F.B., Dellinger R.P., Fein A.M., Knaus W.A., et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis, American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference. Chest 101 (1992) 1644-1655
7. Le Gall J.R., Lemeshow S., and Saulnier F. A new simplified acute physiology score (SAPS II) based on a European/North American Multicenter Study. JAMA 270 24 (1993) 2957-2963
8. Witthaut R., Busch C., Fraunberger P., Walli A., Seidel D., Pilz G., et al. Plasma atrial natriuretic peptide and brain natriuretic peptide are increased in septic shock: impact of interleukin-6 and sepsis-associated left ventricular dysfunction. Intensive Care Med 10 (2003) 1696-1702
9. Castillo J.R., Zagler A., Carrillo-Jimenez R., and Hennekens C.H. Brain natriuretic peptide: a potential marker for mortality in septic shock. Int J Infect Dis 8 5 (Sep 2004) 271-274
10. De Lemos J.A., McGuire D.K., and Drazner M.H. B-type natriuretic peptide in cardiovascular disease. Lancet 362 (2003) 316-322
11. Torre-Amoine G., Kapadia S., Benedct C., Oral H., Young J.B., and Mann D.L. Proinflammatory cytokine levels in patients with depressed left ventricular dysfunction. J Am Coll Cardiol 27 (1996) 1201-1206
12. Thaik C.M., Calderone A., Takahashi N., and Colucci W.S. Interleukin-1β modulates growth and phenotype of neonatal rat cardiac myocytes. J Clin Invest 96 (1995) 1093-1099
13. He Q., and LaPointe. Interleukin-1β regulation of the human brain natriuretic peptide promotor involves Ras-, Rac-, and p38 kinase-dependent pathways in cardiac myocytes. Hypertension 33 (1999) 283-289
14. Ma K.K., Ogawa T., and de Bold A.J. Selective upregulation cardiac brain natriuretic peptide at transcriptional and translational levels by pro-inflammatory cytokines and by conditioned medium derived from mixed lymphocyte reactions via p38 MAP kinase. J Mol Cell Cardiol 36 4 (Apr 2004) 505-513
15. MacGowan G.A., Mann D.L., Kormos R.L., Feldman A.M., and Murali S. Circulating interleukin-6 in severe heart failure. Am J Cardiol 79 (1997) 1128-1131
16. Tsutamoto T., Hisanga T., Wada A., Maeda K., Ohnishi M., Fukai D., et al. Interleukin-6 spillover in the peripheral circulation increase with the severity of heart failure, and the high plasma level of interleukin-6 is an important prognostic predictor in patients with congestive heart failure. J Am Coll Cardiol 31 (1998) 391-398
17. Talwar S., Squire I.B., Downie P.F., Davies J.E., and Ng L.L. Plasma N terminal pro-brain natriuretic peptide and cardiotrophin 1 are raised in unstable angina. Heart 84 (2000) 421-424
18. Ortega O., Gallar P., Munoz M., Rodriguez I., Carreno A., Ortiz M., et al. Association between C-reactive protein levels and N-terminal pro-B-type natriuretic peptide in pre-dialysis patients. Nephron Clin Pract 97 (2004) c125-c130
19. Jefic D., Lee J.W., Jefic D., Savoy-Moore R.T., and Rosman H.S. Utility of B-tipe natriuretic peptide and N-terminal pro B-type natiuretic peptide in evaluation of respiratory failure in critically III patients. Chest 128 1 (2005) 288-295
20. Tung R.H., Garcia C., Morss A.M., Pino R.M., Fifer M.A., Thompson B.T., et al. Utility of B-tipe natriuretic peptide for the evaluation of intensive care unit shock. Crit Care Med 32 (2004) 1643-1647
21. Meader M., Ammann P., Kiowsky W., and Rickli H. B-tipe natriuretic peptide in patients with sepsis and preserved left ventricular ejection. Eur J Heart Fail 7 7 (2005) 1164-1167